Silvia Quadrini

1.3k total citations
20 papers, 113 citations indexed

About

Silvia Quadrini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Silvia Quadrini has authored 20 papers receiving a total of 113 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Silvia Quadrini's work include Cancer Treatment and Pharmacology (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Economic and Financial Impacts of Cancer (4 papers). Silvia Quadrini is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Economic and Financial Impacts of Cancer (4 papers). Silvia Quadrini collaborates with scholars based in Italy, Malaysia and Spain. Silvia Quadrini's co-authors include Flavia Longo, Teresa Gamucci, Rita De Sanctis, Gelsomina Mansueto, Marisa Di Seri, Ester Del Signore, Bruno Gori, E. Bonizzoni, Gabriella Del Bene and Enrico Cortesi and has published in prestigious journals such as Journal of Clinical Oncology, Gut and Annals of Oncology.

In The Last Decade

Silvia Quadrini

20 papers receiving 112 citations

Peers

Countries citing papers authored by Silvia Quadrini

Since Specialization

Citations

This map shows the geographic impact of Silvia Quadrini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Quadrini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Quadrini more than expected).

Fields of papers citing papers by Silvia Quadrini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Quadrini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Quadrini. The network helps show where Silvia Quadrini may publish in the future.

Co-authorship network of co-authors of Silvia Quadrini

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Quadrini. A scholar is included among the top collaborators of Silvia Quadrini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Quadrini. Silvia Quadrini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study 2023 ·Cancers ·Maurizio Muscaritoli, Alessandra Modena, (unknown), Paolo Marchetti, Roberto Magarotto, Silvia Quadrini, Filomena Narducci, Giuseppe Tonini, (unknown), Luigi Cavanna, Camilla Di Nunzio, Chiara Citterio, Marcella Occelli, Antonia Strippoli, Bruno Chiurazzi, Antonio Frassoldati, Giuseppe Altavilla, A. Lucenti, Fabrizio Nicolis, Stefania Gori	9
2	P3.02c-096 Use of Nivolumab in Elderly Patients with Advanced Squamous NSCLC: Results from the Italian Expanded Access Programme (EAP) 2017 ·Journal of Thoracic Oncology ·Francesco Grossi, Lucio Crinò, Annamaria Catino, Stefania Canova, Angelo Delmonte, Andrea Ardizzoni, Marina Chiara Garassino, Simone Scagnoli, Federico Cappuzzo, D. Turci, Silvia Quadrini, Paola Antonelli, Paolo Marchetti, Armando Santoro, (unknown), Francesco Di Costanzo, Francesca Rastelli, Paolo Sandri, Lorenzo Livi, Filippo de Marinis	2
3	P3.02c-095 Italian Nivolumab Expanded Access Programme: Efficacy and Safety Data in Squamous Non-Small Cell Lung Cancer Patients 2017 ·Journal of Thoracic Oncology ·Lucio Crinò, Paolo Bidoli, Angelo Delmonte, Francesco Grossi, Filippo de Marinis, Andrea Ardizzoni, Fabiana Vitiello, Marina Chiara Garassino, Héctor Soto Parrà, Enrico Cortesi, Federico Cappuzzo, Michele Maio, Marcello Tiseo, D. Turci, Silvia Quadrini, Marco Bregni, Alessandro Morabito, Antonio Palla, Diana Giannarelli, Domenico Galetta	4
4	P1.06-006 Treatment beyond Progression in Patients with Advanced Squamous NSCLC Participating in the Expanded Access Programme (EAP) 2017 ·Journal of Thoracic Oncology ·Federico Cappuzzo, Angelo Delmonte, Serena Capici, Lucio Crinò, (unknown), Paolo Sandri, Lorenzo Livi, Fabiana Vitiello, Diego Signorelli, Luana Calabrò, D. Turci, Silvia Quadrini, Paola Antonelli, (unknown), Francesco Di Costanzo, Francesca Rastelli, Paolo Marchetti, Giovanna Finocchiaro, Enrico Cortesi, Andrea Ardizzoni	5
5	ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study 2017 ·Future Oncology ·Luca Moscetti, Lucia Mentuccia, Patrizia Vici, Silvia Quadrini, Isabella Sperduti, Laura Pizzuti, Agnese Fabbri, Angela Vaccaro, Marcello Maugeri‐Saccà, Maddalena Barba, Domenico Sergi, G. Zampa, Teresa Gamucci	4
6	Efficacy and safety of nivolumab in elderly patients (pts) with advanced squamous non small cell lung cancer (Sq-NSCLC) participating in the expanded access programme (EAP) in Italy 2016 ·Annals of Oncology ·Francesco Grossi, Lucio Crinò, A. Misino, Paolo Bidoli, Angelo Delmonte, Francesco Gelsomino, Claudia Proto, M. Mancini, Lorenza Landi, D. Turci, Silvia Quadrini, Paola Antonelli, Paolo Marchetti, Luca Toschi, (unknown), Francesco Di Costanzo, Francesca Rastelli, Paolo Sandri, (unknown), Filippo de Marinis	5
7	Italian cohort of nivolumab Expanded Access Programme (EAP): efficacy and safety data from a real-world population 2016 ·Annals of Oncology ·Lucio Crinò, Paolo Bidoli, Angelo Delmonte, Francesco Grossi, Filippo de Marinis, Francesca Sperandi, Francovito Piantedosi, Milena Vitali, Héctor Soto Parrà, Simone Scagnoli, Gabriele Minuti, Luana Calabrò, Marcello Tiseo, D. Turci, Silvia Quadrini, Paola Antonelli, Anna Manzo, Irene Prediletto, Diana Giannarelli, Domenico Galetta	1
8	Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy: A “real life” retrospective analysis of progression-free (PFS) and overall survival (OS) according to duration of androgen deprivation therapy. 2016 ·Journal of Clinical Oncology ·Agnese Fabbri, Paolo Marchetti, Enrico Cortesi, Daniele Santini, Teresa Gamucci, Francesco Angelini, Isabella Sperduti, Flavia Longo, (unknown), Annalisa Milano, Silvia Quadrini, (unknown), (unknown), Fabrizio Nelli, Raffaele Ratta, Enzo Maria Ruggeri	1
9	Italian cohort of nivolumab Expanded Access Programme (EAP): Preliminary data from a real-world population. 2016 ·Journal of Clinical Oncology ·Lucio Crinò, Paolo Bidoli, Angelo Delmonte, Francesco Grossi, Filippo de Marinis, Francesca Sperandi, Fabiana Vitiello, Milena Vitali, Héctor Soto Parrà, Simone Scagnoli, Gabriele Minuti, Luana Calabrò, Marcello Tiseo, D. Turci, Silvia Quadrini, Paola Antonelli, Anna Manzo, Irene Prediletto, Diana Giannarelli, Domenico Galetta	4
10	2544 Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective “Real Life” analysis of activity and safety 2015 ·European Journal of Cancer ·Agnese Fabbri, Enrico Cortesi, Paolo Marchetti, Daniele Santini, Teresa Gamucci, Francesco Angelini, Francesca Longo, Annalisa Milano, Maria Mancini, (unknown), Silvia Quadrini, Isabella Sperduti, (unknown), Raffaele Ratta, (unknown), Mario Giovanni Chilelli, Enzo Maria Ruggeri	1
11	Fact- B and Esas in Metastatic Breast Cancer (Mbc) Patients (Pts) Treated with Eribulin: Results of a Multicenter Prospective Observational Study 2014 ·Annals of Oncology ·Lucia Mentuccia, Patrizia Vici, Isabella Sperduti, Laura Pizzuti, Luca Moscetti, Angela Vaccaro, Silvia Quadrini, Emanuela Magnolfi, Agnese Fabbri, G. Zampa, (unknown), Domenico Sergi, Filomena Narducci, (unknown), Teresa Gamucci	1
12	Capecitabine in elderly patients with metastatic breast cancer 2012 ·IRIS Research product catalog (Sapienza University of Rome) ·Rita De Sanctis, Silvia Quadrini, (unknown), Ester Del Signore, (unknown), (unknown), Bruno Gori, Vincenzo Bianco, (unknown), Marisa Di Seri, Flavia Longo, (unknown), (unknown)	3
13	Capecitabine in Elderly Patients with Metastatic Breast Cancer 2012 ·Tumori Journal ·Rita De Sanctis, Silvia Quadrini, Flavia Longo, (unknown), (unknown), Ester Del Signore, (unknown), (unknown), Bruno Gori, Vincenzo Bianco, (unknown), (unknown), Marisa Di Seri	3
14	Evaluation of relapse-free survival in T3N0 colon cancer: The role of chemotherapy—A multicentric retrospective analysis. 2012 ·Journal of Clinical Oncology ·Roberta Grande, Maurizio Cosimelli, (unknown), (unknown), Domenico Corsi, Lorena Rossi, Isabella Sperduti, Agnese Fabbri, Raffaello Mancini, Enzo Maria Ruggeri, Flavia Longo, Silvia Quadrini, G. Zampa, (unknown), Teresa Gamucci	1
15	Combination of aprepitant, palonosetron and dexamethasone as antiemetic prophylaxis in lung cancer patients receiving multiple cycles of cisplatin‐based chemotherapy 2012 ·International Journal of Clinical Practice ·Flavia Longo, Gelsomina Mansueto, (unknown), (unknown), Gabriella Del Bene, (unknown), (unknown), E. Bonizzoni, Silvia Quadrini	30
16	Safety and Efficacy of Oral Vinorelbine and Capecitabine Combination for Metastatic Breast Cancer 2011 ·Journal of Chemotherapy ·(unknown), Rita De Sanctis, Silvia Quadrini, (unknown), (unknown), Ester Del Signore, Bruno Gori, Paolo Grassi, (unknown), Flavia Longo	2
17	What caused gastrointestinal bleeding in a woman with a history of pleural mesothelioma? 2010 ·Gut ·Franco Iafrate, Simone Sibio, Paolo Sammartino, (unknown), (unknown), Fabio Accarpio, Antonio Ciardi, Cesare Hassan, (unknown), Silvia Quadrini, Andrea Laghi, (unknown), (unknown)	1
18	Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 2010 ·Supportive Care in Cancer ·Flavia Longo, Giovanni Mansueto, (unknown), Rita De Sanctis, Silvia Quadrini, Roberta Grande, Bruno Gori, Amelia Altavilla, (unknown), Ester Del Signore, (unknown), Cristina De Luca, (unknown), Enrico Cortesi, Teresa Gamucci, Marisa Di Seri	34
19	WALT trial (Phase I-II): Weekly non-pegylated liposomal anthracycline and taxane combination in first-line breast cancer chemotherapy 2008 ·Journal of Clinical Oncology ·Maria Sofia Rosati, Cristina Raimondi, Silvia Quadrini, Rita De Sanctis, (unknown), Bruno Gori, Ester Del Signore, (unknown), (unknown)	1
20	Zoledronic Acid (Za) and Treatment of Bone Metastasis in Patients With Advanced Lung Cancer (Nsclc and Sclc) 2008 ·Ester Del Signore, Andrea Zivi, Luigi Cerbone, Federica Recine, Cristina Raimondi, Rita De Sanctis, Silvia Quadrini, Paolo Grassi, Maria Sofia Basile, Salvatore Minisola, Valeria Fassino, Francesco Longo, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact